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ABSTRACT
Suppressor of cytokine signaling (SOCS) proteins are
recognized as key feedback inhibitors modulating the
inflammatory activities of macrophages, but compara-
tively little is known about whether and how they affect
phagocytosis. Here, we evaluated the role of SOCS3 in
driving the inflammatory phenotype and phagocytic
uptake of apoptotic cells by human macrophages and
the signaling pathways that are necessary for efficient
phagocytosis. In M1-activated human monocyte-derived
macrophages, SOCS3 silencing, using short interfering
RNA technology, resulted in a decreased expression of
proinflammatory markers and an increased expression
of M2 macrophage markers. Strikingly, we demon-
strated for the first time that SOCS3 knockdown
significantly enhances the phagocytic capacity of M1
macrophages for carboxylate-modified beads and
apoptotic neutrophils. With the use of live-cell video
microscopy, we showed that SOCS3 knockdown rad-
ically affects the temporal dynamics of particle en-
gulfment, enabling more rapid uptake of a second
target and delaying postengulfment processing, as
evidenced by deferred acquisition of phagosome
maturation markers. SOCS3 knockdown impacts on
phagocytosis through increased PI3K and Ras-related
C3 botulinum toxin substrate 1 (Rac1) activity, path-
ways essential for engulfment and clearance of apo-
ptotic cells. Enhanced phagocytosis in SOCS3-
silenced cells was reversed by pharmacological PI3K
inhibition. Furthermore, we revealed that actin poly-
merization, downstream of PI3K/Rac1 activation, was
significantly altered in SOCS3-silenced cells, providing
a mechanism for their greater phagocytic activity. The
findings support a new model, whereby SOCS3 not
only plays an important role in driving macrophage
inflammatory responses but modulates key signaling
pathways organizing the actin cytoskeleton to regulate
the efficiency of phagocytic processes. J. Leukoc. Biol.
100: 771–780; 2016.
Introduction
Macrophages are highly heterogeneous cells that can adopt
many phenotypes and functions to shape immune responses and
maintain and restore tissue homeostasis. The properties macro-
phages develop are determined by integration of signals from
their microenvironment. Microbial products and IFN-g (M1
activation), for example, can drive proinﬂammatory, micro-
bicidal, and tumoricidal macrophages, whereas IL-4 (M2
activation) results in anti-inﬂammatory, tissue-healing macro-
phages [1, 2]. These are, however, extremes on a continuum of
the phenotypes found in vivo. A recent macrophage classiﬁcation
has now been proposed based on their activation conditions and
provides a common framework for macrophage activation
nomenclature [3]. A fundamental function of macrophages for
conserving homeostasis and resolving inﬂammation is engulf-
ment and clearance of apoptotic cells [4–7]. This uptake results
in production of anti-inﬂammatory cytokines, including TGF-b
and IL-10 [8], which inhibits inﬂammatory mediator production,
further dampening the inﬂammation (reviewed in ref. [6]).
Failure of apoptotic cell clearance promotes secondary post-
apoptotic necrosis with release of proteolytic enzymes and other
inﬂammatory molecules [9]. As such, defective apoptotic cell
clearance, especially apoptotic neutrophils, impedes resolution
and can lead to the development of autoimmunity or in-
ﬂammatory diseases, such as rheumatoid arthritis and pulmonary
ﬁbrosis. Therapeutic approaches designed to enhance macro-
phage clearance of apoptotic cells could therefore improve the
resolution of inﬂammation. Recognition of apoptotic cells by
macrophages activates several signaling cascades, including Rac1,
causing actin reorganization and cell engulfment [10, 11].
However, the intracellular mechanisms and pathways controlling
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their activity are not well deﬁned, especially in primary human
macrophages.
SOCS are a widely expressed family of intracellular proteins
[SOCS1–7 and cytokine-inducible Src homology 2 domain-
containing protein (CIS)] with important roles in immune
regulation [12–15]. They are best known for their negative-
feedback inhibition of the JAK-STAT pathways but also regulate
other signaling cascades, including PI3K, MAPK, and NF-kB
pathways [12–15]. We [16–18] and others [19–21] have shown
that SOCS proteins, especially SOCS1 and SOCS3, are critical in
regulating the pro- and anti-inﬂammatory functions of macro-
phages both in vivo and in vitro. Expression of SOCS1 and SOCS3
is rapidly up-regulated by a variety of stimuli, and they each have
distinct roles in shaping macrophage functions. SOCS1 is best
known for its role in inhibiting IFN-g and TLR4 signaling, and
SOCS1 knockout mice die from neonatal fatal inﬂammatory
disease, where IFN-g is the chief cause of the resultant pathology
[22–24]. By contrast, SOCS3 regulates signaling mediated by the
common IL-6R family subunit gp130 to limit IL-6-induced STAT1
gene expression and inhibit IL-6-induced STAT3 anti-
inﬂammatory effects [25–27]. In SOCS3-deﬁcient murine macro-
phages, IL-6 behaves more like the immunosuppressive cytokine
IL-10, through prolonged STAT3 activation and suppression of
LPS signaling [27]. We [17, 18] and others [28, 29] have
previously shown that rodent M1 macrophage activation, in vitro
and in vivo, is strongly associated with increased SOCS3 expression
that controls proinﬂammatory functions. However, the effects of
SOCS3 expression on regulating human macrophage phenotypes
and their speciﬁc functions—for example, phagocytic
efﬁciency—have not been determined.
Here, we examined the hypothesis that SOCS3 is important in
controlling pathways driving phagocytosis, and its deﬁciency
enhances uptake of apoptotic cells in human macrophages. Our
results show that macrophage SOCS3 limits phagocytic uptake via
inhibition of a unique PI3K/Rac1/actin remodeling pathway.
They provide new insights into the role of SOCS3 in macrophage
phagocytosis of apoptotic cells and suggest that up-regulation of
SOCS3 expression in the initial stages of inﬂammation could
inhibit apoptotic cell uptake and early switching of macrophage
function, thus driving an efﬁcient inﬂammatory response.
MATERIALS AND METHODS
Cell isolation
Human monocyte-derived macrophages and neutrophils were isolated from
blood of healthy adult-consenting donors, as approved by the Ethics Review
Board of the College of Life Science & Medicine, University of Aberdeen.
Neutrophils and PBMCs were fractionated by density gradient centrifugation.
Monocytes were isolated from the PBMCs by positive selection using human
CD14 microbeads to ensure a highly puriﬁed population (Miltenyi Biotec,
Bergisch Gladbach, Germany) and differentiated into macrophages over
7 d in DMEM (Lonza, Basel, Switzerland), supplemented with 1% L-glutamine,
2% penicillin/streptomycin (GE Healthcare Life Sciences, Buckinghamshire,
United Kingdom) and 10% human AB+ serum [18], using current experimental
guidelines [3].
Gene silencing
Knockdown experiments were performed using predesigned and validated
siRNA for SOCS3 (s17191; Thermo Fisher Scientiﬁc Life Sciences, Waltham,
MA, USA) or a nontargeting siRNA sequence control (4390844; Thermo
Fisher Scientiﬁc Life Sciences). Macrophages were transfected using Lip-
ofectamine RNAiMAX (Thermo Fisher Scientiﬁc Life Sciences) in serum-free
medium, according to the manufacturer’s instructions, as described pre-
viously [18]. In brief, at d 8 of differentiation, macrophages were plated in
antibiotic-free medium and transfected. After overnight incubation, the
medium was supplemented with antibiotics and cells incubated at 37°C for
48 h before treatment. SOCS siRNA transfection efﬁciency was 89 6 9%, as
determined by counts for the number of macrophages containing ﬂuores-
cently tagged siRNA (Thermo Fisher Scientiﬁc Life Sciences). Knockdown
efﬁcacy was analyzed by means of PCR and Western blotting and was
typically 75–90% (Supplemental Fig. 1). For scoring of effects of SOCS3
knockdown on individual cells, at least 100 cells were analyzed to ensure
that the majority analyzed had effective silencing. The transfection
procedure does not interfere with the phagocytic abilities of the cell, as
determined by a comparison among control, siRNA-transfected cells, mock
transfected cells (Lipofectamine RNAiMAX only), and nontransfected
control cells.
RNA extraction and quantitative RT-PCR
Total cellular RNA was isolated from untreated or cytokine-stimulated human
monocyte-derived macrophages using Trizol extraction reagent (Thermo
Fisher Scientiﬁc Life Sciences), followed by RNA clean-up using an RNeasy
Mini Kit (Qiagen, Germantown, MD, USA), according to the manufacturer’s
instructions. A total of 5 mg from each sample was reverse transcribed using
the First Strand cDNA Synthesis Kit and Oligo(dT) 15 Primer (Promega,
Southampton, United Kingdom) and SuperScript II (Thermo Fisher Scientiﬁc
Life Sciences), as recommended by the manufacturers. For each gene, the
PCR was performed on 50, 100, and 200 ng of the cDNA using the following
primers: TNF-a forward (cgctccccaagaagacag), TNF-a reverse (agaggctgag-
gaacaagcac); SOCS3 forward (cttcgactgcgtgctcaa), SOCS3 reverse (gtaggtggc-
gaggggaag); IL-6 forward (gatgagtacaaaagtcctgatcca), IL-6 reverse
(ctgcagccactggttctgt); HLA-DR forward (acaactacggggttgtggag), HLA-DR re-
verse (gctgcctggatagaaaccac); TGM2 forward (ggcaccaagtacctgctca), TGM2
reverse (agaggatgcaaagaggaacg); MRC1 forward (ttcagaaggttttacttggagtga),
MRC1 reverse (tctccataagcccagttttca); SOCS1 forward (cccctggttgttgtagcag),
SOCS1 reverse (gtaggaggtgcgagttcagg); MARCO forward (ggaaactggaactagg-
gagaga), MARCO reverse (cctcccgaagtcacctttact). Quantitative real-time PCR
was carried out by LightCycler 480 (Roche Diagnostics, West Sussex,
United Kingdom) with the Universal Probe Library system (Roche Diagnos-
tics). Gene expression was analyzed using the comparative threshold method
with target gene mRNA levels being normalized to GAPDH and hypoxanthine
phosphoribosyltransferase. Data are expressed as fold-change differences in
gene levels in SOCS3 siRNA-transfected cells compared with that of
transfected with control, nontargeting siRNA.
Phagocytosis assays
Phagocytosis assays of latex beads or apoptotic neutrophils were performed
in SOCS3 siRNA or scrambled control siRNA-transduced macrophages,
activated with 100 ng/ml LPS and 20 ng/ml IFN-g for 3 h. Carboxylate-
modiﬁed latex beads were used as simpliﬁed targets that mimic the surface
charge of apoptotic cells. Neutrophils were separated from whole blood using
Histopaque (Sigma-Aldrich, Irvine, United Kingdom) density gradient
centrifugation (#1119 and #1077). Apoptotic neutrophils were obtained by
culturing neutrophils in RPMI for 1 d, which typically resulted in .70%
apoptotic cells, as determined by Annexin V and propidium iodide staining.
Macrophages were labeled with Vybrant DiD (Thermo Fisher Scientiﬁc Life
Sciences) and apoptotic neutrophils with Vybrant DiO (Thermo Fisher
Scientiﬁc Life Sciences) as recommended by the manufacturer. For uptake
(continued from previous page)
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assays, 10 mm carboxylated polystyrene beads (Polysciences, Eppelheim,
Germany) were added to macrophages at a ratio of 3:1 (bead:macrophage);
for apoptotic neutrophil assays, cells were added at a ratio of 10:1
(apoptotic neutrophils:macrophage). At the end of the incubation period,
typically 3 h after bead/neutrophil addition, nonengulfed cells were
removed by washing. Macrophages were ﬁxed in 4% paraformaldehyde and
the percentage of macrophages phagocytosing at least 1 bead/apoptotic
neutrophil (green ﬂuorescence) determined. PI was calculated as the mean
number of beads or apoptotic neutrophils per 100 phagocytosing
macrophages and provides an indication of the phagocytic efﬁciency of the
macrophages. At least 100 macrophages were designated for analysis. In
selected experiments, macrophages were preincubated with the PI3K
inhibitor LY294002 (10 mM), 1 h before bead addition and determination
of percent phagocytosis and PI. Incubation with DMSO served as vehicle
control.
Phagosome maturation
To quantify phagosome maturation in SOCS3 knockdown macrophages,
10 mm polystyrene beads were added at a ratio of 3:1, following 3 h
activation with LPS and IFN-g. Cells were washed in ice-cold PBS and
ﬁxed for 15 min in 4% paraformaldehyde and permeabilized with 0.1%
Triton X-100. Cells were blocked in 10% milk powder, 0.3% Tween-20 in
PBS, and then ﬂuorescently stained with the late phagosome
maturation marker LAMP-1 for 1 h at room temperature. Cells were
imaged using a Zeiss Axio Observer Z1 inverted microscope (Carl Zeiss
AG, Oberkochen, Germany) with a mature phagosome deﬁned as a
“halo”-like ring surrounding an ingested bead, as previously described by
our laboratory [30]. Maturation was then calculated as the
number of mature rings divided by total beads ingested, multiplied by 100.
Live-cell imaging
Human monocyte-derived macrophages were cultured at 1.2 3 105 cells/well
in ibidi 8-well, glass-bottom m-slides (Thistle Scientiﬁc, Uddingston, United
Kingdom). Time-lapse images were acquired over a 3 h period postbead/cell
addition using an UltraVIEW VoX spinning disk microscope (Nikon, Surrey,
United Kingdom). Images were captured at 1 min intervals using 320
magniﬁcation at 37°C with an electron-multiplying, charge-coupled device
back camera C9100-50 (Hamamatsu, Shizouka, Japan) and Volocity software
(6.3 software; Improvision, PerkinElmer, Coventry, United Kingdom). Cells
were bathed in CO2 independent media (Thermo Fisher Scientiﬁc Life
Sciences) while imaging. Videos were ﬁrst optimized, keeping adjustments
constant for every video and exported for quantiﬁcation in ImageJ (Cell
Counter and Chemotaxis plugins; NIH, Bethesda, MD, USA). More than
100 macrophages were selected and followed individually for each exper-
iment. The percentage phagocytosis was calculated from the numbers of
macrophages that contained a fully engulfed bead or demonstrated green
ﬂuorescence from ingested neutrophils; PI was calculated as above. At the end
of each video, the number of beads engulfed by individual macrophages
was counted and graphed according to the percentage of macrophages
engulﬁng a deﬁned number of beads. For distribution of neutrophil uptake,
the maximum CTCF was determined per movie and divided into 10% groups.
The CTCF of each phagocytosing macrophage was quantiﬁed and allocated
into these percentiles, producing a distribution of CTCF levels. For
quantifying macrophage motility, cells were picked at random at the
beginning of each individual movie and their movement tracked using
ImageJ (NIH) or Volocity 6.3 image analysis software (Improvision,
PerkinElmer), measuring total distance traveled [the total length
(micrometers) of the trajectory that the cell has migrated]; Euclidian
distance [the straight-line distance (micrometers) between the position of
the cell at the start (T = 0) and the end of the migration assay]; average
velocity [the total distance migrated (micrometers)/time in hours]; and
the directionality of cell movement (Euclidian distance/total distance
traveled). Uptake speed of the ﬁrst and subsequent beads was quantiﬁed
from the time of ﬁrst contact of the macrophage with a bead until the
bead was fully enveloped.
Western blotting
Protein lysates were prepared from SOCS3 knockdown or control, scrambled
siRNA-transduced macrophages, following 3 h activation with LPS and IFN-g
and 1 h with 10 mm carboxylated-modiﬁed polystyrene beads. A total of 20 mg
protein was separated by SDS-PAGE and transferred to the Hybond-P
polyvinylidene diﬂuoride membrane (Amersham, GE Healthcare, Pittsburgh,
PA, USA) for Western blot analysis with speciﬁc primary antibodies for Akt
and p-Akt ser473 (Cell Signaling Technology, Danvers, MA, USA), SOCS3
(Abcam, Cambridge, United Kingdom), and b-actin (Sigma-Aldrich).
Immunolabeled proteins were detected using appropriate HRP-conjugated
secondary antibodies, followed by visualization with ECL (GE Healthcare).
Bands were normalized to b-actin.
Pulldown assay for Rac1 activation
To detect active, GTP-bound Rac1, a pulldown assay using a Rac1 activation
assay kit was performed, according to the manufacturer’s instructions
(Abcam). In brief, human macrophages were treated with 100 ng/ml LPS,
20 ng/ml IFN-g, and carboxylated modiﬁed beads for 30 min, and the cells
were lysed in a Rac1 lysis buffer containing protease inhibitors and GST-PAK-
CRIB, a GST fusion of CRIB of PAK that selectively precipitates the activated
form of Rac1. Extracts from unstimulated and nontransfected cells were
spiked with Rac1-GDP and Rac1-GTP-g-S to serve as controls for the speciﬁcity
of the afﬁnity puriﬁcation. The spikes were incubated at 30° for 15 min with
constant agitation, samples centrifuged, and the supernatant harvested for
determination of Rac1 activation. Lysate (40 ml) was collected for total Rac1,
which was used as an internal loading control for active Rac1. Glutathione-
Sepharose beads were added to the remaining sample lysates and incubated
for 30 min under constant mixing at 4°C. The beads and precipitated proteins
were washed 3 times with ice-cold lysis buffer. The resulting pulldown
(active Rac1) and total Rac1 was then immunoblotted with Rac1 antibody,
according to the manufacturer’s instructions, and immunoblotted proteins
were detected using an ECL-based detection system (GE Healthcare).
Live imaging of actin cytoskeleton
Human monocyte-derived macrophages transfected with control, scrambled
siRNA or SOCS3 siRNA were labeled using an SiR-Actin detection probe
(Spirochrome, Stein am Rhein, Switzerland) for live-cell imaging of the
cytoskeleton, based on a silicon rhodamine ﬂuorophore and the F-actin-
binding small molecule, jasplakinolide [31]. Live-cell staining was attained by
adding 500 nM of the probe to DMEM complete medium and incubated at
37°C in a 5% CO2 incubator for 2 h before imaging. Macrophages were
treated with 100 ng/ml LPS and 20 ng/ml IFN-g. Immediately before
imaging, DMEM was replaced with 2 ml prewarmed, supplemented CO2
-independent media (Thermo Fisher Scientiﬁc Life Sciences) containing
10 mm carboxylate-modiﬁed beads at a 3:1 beads:macrophage ratio. Images
were captured by Volocity 6.3 software (Improvision, PerkinElmer) every
minute over a 3 h period. At least 3 independent experiments were performed
with a minimum of 4 movies per experiment. For reliable quantiﬁcation, all
images were captured with the same camera setting (Ultraview 640 nm
laser power, exposure time, and back camera sensitivity). In selected
experiments, cells were ﬁxed with 4% paraformaldehyde, labeled with SiR-
Actin, and Z stacks obtained using a 340 oil objective and a Zeiss LSM 710
confocal microscope. Maximum intensity projections were generated from
the acquired 3-dimensional images using Zen software. From each in-
dependent experiment, at least 30 macrophages were randomly selected
for quantiﬁcation of macrophage area and mean ﬂuorescence intensity
analysis and calculated using ImageJ software.
Statistics
Statistical analyses were performed using GraphPad Prism 5. Student’s 2-tailed
t tests were performed, where appropriate, to assess the signiﬁcance of
differences. In the absence of normal distribution, signiﬁcance was de-
termined by a Mann-Whitney and Wilcoxon signed-rank tests. Uniform or
random distribution was assessed using the Rayleigh distribution test.
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RESULTS
SOCS3 knockdown alters the expression of
inﬂammatory markers and increases phagocytosis in
human monocyte-derived macrophages
Previous studies have shown SOCS3 to be important in
controlling the inﬂammatory status of rodent macrophages and
their ability to prime and induce T cell responses [17–19]. Our
initial experiments determined whether SOCS3 also plays a role
in directing the phenotypic characteristics of M1-activated
human monocyte-derived macrophages by SOCS3 silencing and
gene expression analysis of macrophage markers. SOCS3
knockdown results in a decrease in expression of proinﬂamma-
tory genes (TNF, IL-6, HLA-DR), while enhancing those markers
associated with M2 macrophages (mannose receptor, TGM2, and
SOCS1); by contrast, MARCO showed a minimal change in
expression levels (Fig. 1 and Supplemental Fig. 1A–D). There-
fore, these results conﬁrm the efﬁciency of our knockdown
system and the importance of SOCS3 in driving speciﬁc
proinﬂammatory characteristics of human macrophage.
A key function of macrophages in regulation of inﬂammation
is efﬁcient clearance of apoptotic cells that subsequently induces
characteristics of M2 anti-inﬂammatory macrophages [6, 8, 32].
To evaluate whether SOCS3 has a signiﬁcant inﬂuence on this
central macrophage function, human monocyte-derived macro-
phages, with or without SOCS3 silencing, were cultured with
carboxylate-modiﬁed latex beads as a surrogate target mimicking
the surface charge of apoptotic cells and the phagocytic ability
determined 1 h postbead addition [7]. Strikingly, there was a
modest but statistically signiﬁcant increase in the percentage of
macrophages phagocytosing beads after SOCS3 knockdown com-
pared with those transfected with control siRNA (Fig. 2A and D),
with a mean increase in uptake rate of 28.5 6 8.1% over control.
Macrophage preparations from every human donor tested (n = 6)
displayed such increased phagocytic responses. There was a
corresponding signiﬁcant increase in the PI after SOCS3 knock-
down, increasing, on average, by 47.7 6 13.2% over that of control
siRNA-transfected cells (Fig. 2B and E). Following uptake, the
engulfed particles are trafﬁcked into a series of increasingly
acidiﬁed membrane-bound structures, leading to phagosome
maturation and particle degradation [7, 33]. There is growing
evidence that the rate and extent of phagosome maturation differ
with the activation state of the macrophage [34]. Here, we found
that phagosome maturation, as identiﬁed by acquisition and
staining with the classic late maturation marker LAMP-1 [30], was
delayed in SOCS3-silenced cells (Fig. 2C and F), with a 24.26 3.5%
decrease, again highlighting the importance for SOCS3 in
controlling this process.
We next established detailed kinetics of the increase in
phagocytosis in SOCS3 knockdown macrophages compared with
control siRNA-transfected macrophages by using time-lapse live-
cell imaging and confocal microscopy to follow uptake of
carboxylate-modiﬁed beads or the more physiologic substrate of
apoptotic neutrophils. Figure 3A and B (and Supplemental
Videos 1 and 2) show exemplary events of macrophages
migrating toward beads or apoptotic cells, respectively, and their
subsequent engulfment. A signiﬁcant increase in bead uptake
was observed after 1 h incubation in SOCS3 knockdown
macrophages, and this increase continued to persist over the 3 h
time course of the experiment (Fig. 3C). The PI was also
signiﬁcantly enhanced in SOCS3 knockdown macrophages over
time, conﬁrming an increase in overall proﬁciency of phagocytosis
in these cells (Fig. 3D). As with carboxylate-modiﬁed beads, there
was a signiﬁcant increase in the percentage phagocytosis (Fig. 3E)
and PI (Fig. 3F) of apoptotic neutrophils over time in SOCS3
knockdown compared with control, siRNA-transfected cells; how-
ever, the signiﬁcant difference in the uptake efﬁciency was
observed much earlier, from 15 min postincubation. This early
response with SOCS3 knockdown macrophages suggests that effects
on phagocytosis were direct and not a secondary consequence of
altered gene expression over the time scale examined.
To extend our analysis of the differences in rate of
phagocytosis in SOCS3 knockdown macrophages, total numbers
of carboxylic beads or apoptotic neutrophils taken up by
individual macrophages over a 3 h period were recorded. Most
macrophages engulfed more than 1 bead or apoptotic cell (Fig.
4A and B); however, in the SOCS3 knockdown group, there
were, overall, larger numbers of beads engulfed, with only the
SOCS3 knockdown macrophages engulﬁng $11 beads (Fig. 4A).
This was also reﬂected when macrophages phagocytosed
apoptotic neutrophils, with a higher number of SOCS3-silenced
cells compared with control siRNA-transfected cells displaying
enhanced ﬂuorescence values, indicative of more engulfment
(Fig. 4B). Collectively, these results demonstrate that SOCS3
expression is important in controlling the degree of phagocyto-
sis, and without it, the levels and rate of uptake are improved.
SOCS3 silencing had no effect on macrophage mobility
but did increase the kinetics of engulfment
A potential factor causing the increased phagocytosis observed
in SOCS3-silenced macrophages is an alteration in the migration
Figure 1. SOCS3 silencing decreased M1 and increased M2 macrophage
inﬂammatory markers. Human monocyte-derived macrophages were
transfected with control scrambled siRNA or SOCS3-speciﬁc siRNA and
activated by IFN-g/LPS for 6 h. mRNA expression was analyzed by
quantitative PCR for the proinﬂammatory markers SOCS3, TNF, IL-6,
HLA-DR, and MARCO and anti-inﬂammatory markers mannose re-
ceptor (MR), TGM2, and SOCS1. Values are normalized to a
housekeeping gene (GAPDH) and shown as relative fold change in
expression of genes in SOCS3 knockdown macrophages compared with
control, nontargeting siRNA-transfected cells. Values are means 6 SD;
n = 5 different macrophage donor preparations.
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or “search pattern” for their phagocytic target. Therefore, we
determined the migratory kinetics of randomly selected
macrophages over a 3 h uptake period. Quantitatively, there was
no signiﬁcant differences in total distance traveled (Fig. 5A),
Euclidian distance (straight line distance between the macro-
phage and phagocytic substrate; Fig. 5B), or velocity of the cells
(Fig. 5C) observed for SOCS3 knockdown versus control
siRNA-transduced macrophages. Moreover, there was no
statistical difference in the directionality, a measure of
migration randomness of the cells, as assessed using the
Rayleigh uniformity test (Fig. 5D). Therefore, it was important
to establish whether the increase in phagocytosis in the
Figure 3. SOCS3 knockdown in human macro-
phages increases phagocytosis. Exemplary events
of human macrophage migration toward their
target and subsequent engulfment. Images were
acquired from time-lapse video microscopy im-
ages during the incubation of LysoTracker Red-
labeled human macrophages with carboxylate-
modiﬁed latex beads (A) or Vybrant DiD-labeled
macrophages (red) with green Vybrant DiO
ﬂuorescently labeled apoptotic neutrophils (B).
The arrows indicate the uptake of beads (phagosomes
gradually increased in ﬂuorescence intensity after
the particles were internalized) or apoptotic
neutrophils over time in snapshot serial images.
Engulfment was deﬁned as membrane closure
on the far side of the bead or the transfer of
Vybrant DiO neutrophil dye (green) into the
Vybrant DiD-labeled macrophage (red). Times
displayed represent individual points from the
start of the video monitoring uptake. The mean
percentage of macrophages engulﬁng beads (C)
and corresponding PI (D) or macrophages engulﬁng
apoptotic neutrophil (E) and corresponding PI
(F) in SOCS3 knockdown macrophages versus
control siRNA-transfected cells. Means 6 SEM.
*P , 0.05, **P , 0.01; n = 6 individual donor
macrophage preparations.
Figure 2. SOCS3 knockdown increases the
percentage of macrophages phagocytosing and
the PI and delays phagosome maturation. Human
monocyte-derived macrophages were transfected
with control scrambled siRNA or SOCS3-speciﬁc
siRNA and incubated with carboxylate-modiﬁed latex
beads. The percent of macrophages phagocytosing
latex beads, the PI, and the percentage of
macrophages containing mature phagosomes
were determined after 1 h for 6 different donor
macrophage preparation (A–C) and mean
values 6 SEM displayed (D–F). *P , 0.05.
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absence of SOCS3 was related to differences in speed of
engulfment of speciﬁc targets; consequently, rates were
examined. The engulfment time was deﬁned as the time from
ﬁrst cell to target contact to complete internalization. In-
terestingly, there was no difference in the uptake rate of the
ﬁrst latex bead engulfed between SOCS3 or control siRNA-
transfected macrophages (Fig. 5E); however, the rate of
engulfment of subsequent beads was signiﬁcantly faster in
SOCS3 knockdown cells (Fig. 5F), suggesting that differences
could relate to events controlling the remodeling of the actin
cytoskeleton.
The depletion of SOCS3 enhances PI3K and Rac1
activity and downstream F-actin organization in
human macrophages
Polymerization of F-actin at initial sites of phagocytosis is de-
pendent on enrichment of phosphatidylinositol 4,5-bisphosphate
in the inner leaﬂet of the plasma membrane, an event highly
dependent on PI3K activity [11]. As SOCS proteins have been
shown to inhibit PI3K activity in other cell systems [18, 35–37],
we sought to determine whether silencing SOCS3 also affected
this pathway in bead-activated macrophages by deﬁning effects
on p-AKT, a downstream substrate and surrogate marker of
Figure 4. SOCS3 knockdown increases the phago-
cytic capacity of human macrophages. Percentage
of macrophages that engulfed a deﬁned number
of carboxylate-modiﬁed beads (1–14) over a 3 h
incubation period for SOCS3 knockdown cells
(gray bars) or control siRNA-transfected macro-
phages (white bars; A). Percentage of macro-
phages that express a deﬁned fraction of the
maximum transferred green DiO apoptotic neu-
trophil dye, indicating uptake, over a 3 h in-
cubation period (B), calculated as described in
Materials and Methods. The ﬁgure is representa-
tive of results from 4 different macrophage
preparations, and at least 100 macrophages were
analyzed per preparation.
Figure 5. Enhanced phagocytosis in SOCS3 knock-
down macrophages is not a result of altered
migration toward latex beads. Control siRNA-
transfected or SOCS3 siRNA-transfected macro-
phages were selected randomly at the beginning
of the phagocytosis videos and their movement
tracked for 3 h using ImageJ tracking software at
deﬁned intervals. Total distance traveled (micro-
meters; A), Euclidian distance (straight line;
micrometers; B), average cell velocity (microme-
ters/hour; C), and directionality of the cells (D)
were calculated as in Materials and Methods.
Values represent means 6 SEM, n = 6 individual
macrophage preparations. Engulfment speed of
the ﬁrst (E) and second (F) bead was quantiﬁed
from the time of ﬁrst contact of the macrophage
with a bead until the bead was fully enveloped
and compared in control siRNA-transfected
and SOCS3 siRNA-transfected macrophages.
***P , 0.001.
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PI3K activity. On activation of phagocytosis with carboxylate-
modiﬁed beads, there was a signiﬁcant increase in p-AKT levels
in SOCS3-silenced macrophages (Fig. 6A), supporting the view
that the increase in phagocytosis observed in these cells is, at
least in part, linked to an increase in PI3K-mediated actin
cytoskeletal rearrangement. To determine whether this pro-
vided a molecular mechanism by which SOCS3 controls
macrophage phagocytosis, we examined the effect of preincu-
bation with the well-known PI3K inhibitor, LY294002. As
previously shown, SOCS3 knockdown resulted in a signiﬁcant
increase in bead uptake (34.7 6 8.3% increase) and PI (56.8 6
7.1%). LY294002 preincubation inhibited baseline phagocyto-
sis by 22.1 6 0.9% in control, siRNA-transfected macrophages, in
line with the importance of this pathway for bead uptake. PI3K
inhibition also abrogated the signiﬁcantly enhanced uptake
observed in SOCS3-silenced macrophages compared with control,
siRNA-transfected cells (P = 0.231; Fig. 6B) and abolished the
increase in PI (Fig. 6C), conﬁrming that PI3K is an essential
component of the enhanced phagocytosis observed in SOCS3-
silenced human macrophages.
PI3Ks interact with GTP-bound forms of the small GTPase,
Rac1, that is key in regulating F-actin polymerization and
reorganization of the actin cytoskeleton for internalization of
apoptotic cells [38, 39]. To address whether SOCS3 silencing
affected this pathway, we determined effects on Rac1 activity.
Analysis of pulldown assays using the CRIB domain of PAK1
conﬁrmed increased levels of active, GTP-bound Rac1 in SOCS3-
silenced macrophages compared with control siRNA-transfected
cells (Fig. 6D). Thus, PI3K activity and Rac1 activation are
both augmented signiﬁcantly in SOCS3-silenced human macro-
phages, conducive to the enhanced phagocytosis observed.
We next investigated whether cell morphology and actin
polymerization/cytoskeletal arrangements were altered in
SOCS3 knockdown macrophages as key downstream events of
PI3K and Rac1 activity. Live imaging using a ﬂuorogenic,
cell-permeable probe, speciﬁc for F-actin [31], revealed that
SOCS3 knockdown macrophages display a striking difference in
morphology compared with control siRNA-transduced macro-
phages (Fig. 7A and B). On activation by latex beads, they
exhibited a more polarized F-actin pattern and stress-ﬁber
distribution at the cell periphery. By contrast control siRNA-
transfected cells displayed a rounded morphology with a punctate
actin arrangement. Moreover, SOCS3 knockdown macrophages
showed an increase in cell size. These observations were veriﬁed
following quantiﬁcation of the macrophage body areas that
demonstrate a signiﬁcantly greater size in SOCS3 knockdown cells
(Fig. 7C). Taken together, our results demonstrate greater activity
of PI3K and Rac1 and subsequent actin polymerization following
SOCS3 knockdown, providing a mechanistic insight into the
enhanced rate of phagocytosis observed in these macrophages.
DISCUSSION
In this study, we demonstrate that SOCS3 is not only essential for
controlling the proinﬂammatory phenotype of human monocyte-
derived macrophages but is also a previously unidentiﬁed
determinant regulating the efﬁciency with which they phagocy-
tose apoptotic cells. We establish a novel mechanism of action,
whereby SOCS3 alters important signaling pathways regulating
uptake, with SOCS3 suppressing PI3K and Rac1 activity, as well as
actin remodeling, to reduce the efﬁciency of phagocytosis. Thus,
Figure 6. SOCS3 knockdown results in an increase
in PI3K activity (p-AKT) and Rac1 activity on
activation of phagocytosis with carboxylate beads.
Human monocyte-derived macrophages were
transfected with control siRNA or SOCS3 siRNA.
Forty-eight hours following transfection, cells were
stimulated with carboxylate-modiﬁed beads and
PI3K activity assessed by Western blotting for
downstream p-AKT. Blotting for SOCS3 conﬁrmed
knockdown. The ﬁgure shows expression of pro-
teins, as determined by an immunoblot, represen-
tative of 3 individual experiments (A). Normalized
densitometric analysis of scanned bands in arbi-
trary units (A. U.) for p-AKT and SOCS3. In-
cubation of SOCS3 knockdown macrophages for
30 min with the PI3K inhibitor LY294002 (10 mM)
before addition of carboxylate-modiﬁed beads for
3 h abrogated the signiﬁcant increase in phago-
cytic activity (B) and PI (C) in SOCS3 siRNA-
transfected macrophages; DMSO (0.15%) served
as a vehicle control. SOCS3 knockdown increases
Rac1 activity, as shown by representative immuno-
blot after pulldown (D) and normalized densito-
metric analysis of scanned bands in arbitrary units
for active Rac1:total Rac1, n = 3; *P , 0.05.
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our studies uncover a new role for SOCS3 in controlling innate
immune responses important in the resolution of inﬂammation.
Swift clearance of apoptotic cells is essential to preserve tissue
integrity and prevent the accumulation of harmful products
released from dying cells [9]. Deﬁcient phagocytosis is associated
with autoimmune diseases because of exacerbated and abnormal
inﬂammatory responses [40]. Here, we demonstrate a consistent
increase in uptake of different substrates by SOCS3-silenced
macrophages, reﬂected in an enhanced PI. As clearance of
apoptotic cells is such a critical event, even a modest increase in
uptake, as was observed here, would be predicted to have
important biologic effects on inﬂammation [9, 40]. It is well
documented that proinﬂammatory stimuli inhibit uptake of
apoptotic cells by M1 macrophages. Moreover, several studies
have demonstrated that SOCS3 is potently up-regulated in M1
macrophages both in vitro and in vivo [12, 17–19, 29]. Our
ﬁndings suggest that the M1-induced up-regulation of SOCS3
expression would play a role in inhibiting apoptotic cell uptake in
the initial immune response and therefore, conserve proinﬂam-
matory functions for efﬁcient pathogen killing [41]. Phagocytosis
of apoptotic cells inhibits SOCS3 expression [42], and we
propose that this inhibition would further boost the phagocytic
capacity for apoptotic cells, as well as switch the macrophage
toward a more anti-inﬂammatory phenotype. It is intriguing that
the phagocytic capacity of SOCS3-deﬁcient M1 murine macro-
phages for Escherichia coli was likewise enhanced compared with
wild-type M1 macrophages; this suggests a common pathway for
uptake of pathogens or apoptotic cells that can be inhibited by
SOCS3 [19].
Live-cell imaging enabled us to analyze quantitatively the
increase in uptake of both latex beads and apoptotic neutrophils
in SOCS3-silenced macrophages. Strikingly, differences were
noted between the engulfment kinetics of the 2 particles. The
enhanced uptake of apoptotic neutrophils was observed much
earlier than seen with beads, and most probably reﬂects the
greater abundance of ligands that interact with phagocytic
receptors on the latter. Uptake rates can reﬂect the initial
recognition and interaction of macrophages with their substrate,
and kinetic studies permitted calculations of the migration rate
of macrophages toward their substrate, the distance traveled for
interaction, and the overall directionality. However, none of
these physical changes was altered by SOCS3 knockdown, and so
pathways controlling initial contact with macrophages are not
the main target but rather, events associated with speed and
efﬁciency of uptake. This was highlighted by the observations that
the uptake rates increased after engulfment of the ﬁrst particle
in SOCS3-silenced macrophages and that postengulfment pro-
cessing and phagosome maturation were delayed. These en-
hanced kinetics could account for the greater number of beads
and neutrophils engulfed overall in SOCS3-silenced cells.
Apoptotic cell uptake is controlled by a complex network of
signaling pathways. PI3K activity is a critical for protrusion of the
plasma membrane during phagocytic cup formation and for
phagosomal closure [11]. The PI3K products, p-Akt and
phosphatidylinositol 3,4,5-triphosphate, promote efﬁcient uptake
of apoptotic cells. Previous studies, including our own, have
shown the ability of SOCS3 to inhibit PI3K-mediated signaling in
other biologic contexts, including inﬂammatory responses
[18, 35–37]. This also appears to be the case in bead-activated
macrophages, where we found SOCS3 inhibition signiﬁcantly
enhanced PI3K activity, and inhibition of PI3K prevented the
enhanced phagocytosis in SOCS3-silenced cells. A limitation of
these studies, however, is that the PI3K inhibitor, LY294002,
resulted in a marginal decrease in basal phagocytosis. Therefore,
if the LY294002-induced dampening of phagocytosis is down-
stream of SOCS3 and at the level of p-AKT activity, then the
signiﬁcant inhibition of phagocytosis observed in SOCS3
knockdown macrophages with this drug may not be entirely
related to SOCS3 silencing per se. PI3K-dependent activation of
Rac1 is also indispensable for cytoskeletal rearrangements and
inducing membrane rufﬂing and lamellipodial extensions [11].
All forms of apoptotic cell uptake tested to date have a strict
requirement for Rac1 for engulfment, including apoptotic cell
Figure 7. SOCS3 knockdown in human macrophages alters actin
distribution, as determined by live-cell imaging. Human monocyte-
derived macrophages transfected with control, scrambled siRNA (A) or
SOCS3 siRNA (B) were ﬂuorescently stained with SiR-Actin for live-cell
imaging of the actin cytoskeleton. Images were captured every minute
over a 3 h period. (A and B) Maximum intensity projections from
3-dimensional confocal images of ﬁxed cells created from Z stacks using
Zen software, also showing a punctate and polarized actin distribution
(white arrows) for control siRNA- and SOCS3 siRNA-transfected cells,
respectively. Original magniﬁcation, 3400. At least 3 independent
experiments were performed with a minimum of 4 movies per
experiment. Macrophages (n $ 30) were randomly selected to de-
termine macrophage area (micrometers). The cell-body area and
perimeter were identiﬁed and measured using ImageJ on the captured
images (C). Data are expressed as means 6 SEM.
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clearance by bronchial epithelial cells and clearance of dying
cells by Caenorhabditis elegans [43, 44]. The up-regulation of Rac1
activity with SOCS3 knockdown further emphasizes the impor-
tance of SOCS3 in controlling this arm of the signaling pathway
in phagocytosis, and overall, we propose that SOCS3 modulation
of PI3K, Rac1, and actin cytoskeletal arrangements is key to this
process. However, it is also plausible that SOCS3 inhibits
phagocytosis by synergizing with other mechanisms. FAK is a key
tyrosine kinase linking integrins to downstream Rac-speciﬁc
guanine nucleotide exchange factors, which in turn, regulate
actin polymerization or turnover to induce particle engulfment
[45]. SOCS3 was found to inhibit FAK-associated kinase activity
and FAK tyrosine phosphorylation [46]. SOCS proteins also
promoted polyubiquitination and degradation of FAK in a SOCS
box-dependent manner and inhibited FAK-dependent signaling
events, such as cell motility on ﬁbronectin. This may provide
an alternative mode of action for SOCS3 in controlling
phagocytic uptake, although FAK activation is not a main
pathway driving apoptotic cell uptake in resolution of inﬂam-
mation. SOCS3 inhibits STAT3 activation, and deﬁciency in
myeloid lineage cells has been shown to prolong activation of
STAT3 [17–19]. Inhibition of STAT3 signaling also results in a
decreased clearance of apoptotic cells [42, 47], thus SOCS3, by
inhibiting STAT3, could potentially regulate cell uptake through
this mechanism. However, SOCS3 speciﬁcally inhibits gp130-
induced STAT3 activation, and whether this is operational
during the uptake process requires further study.
Organized actin polymerization at the phagosome is pivotal for
engulfment [6, 10, 11]. We evaluated the functional effect of
SOCS3 knockdown on the distribution of F-actin using live-cell
imaging. It is striking that SOCS3-silenced cells appeared to show
a greater cell area and a more organized appearance of actin
ﬁbers. The greater membrane area and polarized actin
distribution is conducive to the enhanced uptake of particles
observed in our studies and would be downstream of effects on
PI3K and Rac1 [48].
SOCS3 can selectively control multiple pathways to ﬁne tune
macrophage proinﬂammatory properties [17–20]. We also show
here that in the absence of SOCS3, M1-activated human
macrophages default to a less-proinﬂammatory phenotype, as
determined by gene-expression analysis. This is in line with our
previously published results showing changes in inﬂammatory
mediators (TNF, IL-1b, IL-6, IL-12p70, IL-23, SOCS1, and HLA-
DR) in IFN-g/LPS-activated SOCS3 knockdown macrophages
at the protein level [17, 18]. The exact mechanisms relating to
this were not addressed in the present study, but we [17, 18] and
others [19, 20] have previously shown that in SOCS3 knockout
and knockdown rodent M1-activated macrophages, the decrease
in inﬂammatory functions especially relates to changes in
STAT3; PI3K (increased and anti-inﬂammatory); and NF-kB,
MAPK, and Notch signaling (decreased and proinﬂammatory).
Moreover, when Notch signaling was blocked, M1 stimuli
induced a M2 response, and it was proposed that this was a result
of the downstream effects on SOCS3 [20]. TNF expression was
down-regulated with SOCS3 silencing, and this cytokine is known
to block M2 polarization in a gene-speciﬁc way, providing an
alternative mechanism by which SOCS3 controls activation [49].
The alteration in phenotypic markers in SOCS3 knockdown
human macrophages is in contrast to results in M1-activated
macrophages obtained from myeloid-speciﬁc SOCS3-deﬁcient
mice [19], where SOCS3 deﬁciency enhanced expression of
selected proinﬂammatory cytokine genes, in spite of enhanced
STAT3 activation; the effect on M2 gene expression was not,
however, determined. The reasons for the discrepancy in
ﬁndings are unclear but could relate to differences in LPS
concentration, timing of mRNA isolation after stimulation, and
importantly, technologies and species used, for example, siRNA-
mediated knockdown in rodent and human macrophages versus
bone marrow cells from myeloid-speciﬁc SOCS3 knockout mice.
In summary, our results provide a novel mechanistic insight
into the role of SOCS3 in primary human macrophages,
suggesting that SOCS3 not only drives macrophage inﬂammatory
responses but also controls pathways involved in actin remodel-
ing to regulate the efﬁciency of phagocytic events. Thus, SOCS3
expression has dual effects relevant to the resolution of injury or
infection. Therefore, strategies for SOCS3 modulation offer an
opportunity for pharmacological targeting to both restrict
inﬂammatory responses and additionally, to accelerate phago-
cytic clearance and resolution of inﬂammation in diseases, such
as atherosclerotic plaques, where both inﬂammation and de-
fective clearance of apoptotic cells play a signiﬁcant part [9].
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